BAKER BROS. ADVISORS LP

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1263508 NEW YORK, NY

Position in TSHA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$17,901,259

-$4,124,899 QoQ

Shares Held

4,004,756

0.0% QoQ

Ownership

1.39%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BAKER BROS. ADVISORS LP holds $16,600,149,582 across 76 Biotechnology names. TSHA ranks #53 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	30,744,412	$2,893,664,057
2	ONC	BeOne Medicines Ltd.	8,799,053	$2,613,054,769
3	INSM	INSMED Inc	7,421,111	$1,213,500,070
4	MDGL	Madrigal Pharmaceuticals, Inc.	2,141,701	$1,121,116,222
5	ACAD	Acadia Pharmaceuticals Inc	42,896,690	$954,880,319
6	RVMD	Revolution Medicines, Inc.	9,555,357	$929,258,468
7	CELC	Celcuity Inc.	7,915,792	$903,508,498
8	KOD	Kodiak Sciences Inc.	19,919,186	$759,319,370

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$17,901,259	4,004,756	0.0%	Shares	Sole	2026-05-15
2025-12-31	$22,026,158	4,004,756	0.0%	Shares	Sole	2026-02-17
2025-09-30	$13,095,552	4,004,756	0.0%	Shares	Sole	2025-11-14
2025-06-30	$9,250,986	4,004,756	0.0%	Shares	Sole	2025-08-14
2025-03-31	$5,566,610	4,004,756	0.0%	Shares	Sole	2025-05-15
2024-12-31	$6,928,227	4,004,756	0.0%	Shares	Sole	2025-02-14
2024-09-30	$8,049,559	4,004,756	0.0%	Shares	Sole	2024-11-14
2024-06-30	$8,970,653	4,004,756	0.0%	Shares	Sole	2024-08-14
2024-03-31	$11,493,649	4,004,756	0.0%	Shares	Sole	2024-05-15
2023-12-31	$7,088,418	4,004,756	+59.9%	Shares	Sole	2024-02-14
2023-09-30	$7,915,028	2,504,756	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.